ARCHIVES

Melanoma Vaccine Near Phase 3, Other Studies Discussed At ACS Seminar

This article is from The Cancer Letter archive.

Vol. 16 No. 15 | April 13, 1990

Download PDF Visit The Full Archive

Related Articles

NCI Advisors Criticize a Biomarker Study Touted as High Priority for NCI and FDA.

July 13, 2007

J&J Withdraws Power Morcellators, Citing Risk of Disseminating Cancer

August 1, 2014

NCI’s Justification For 1981 Budget

June 8, 1979

Foundation Issues Call For Tobacco Policy Research Proposals

November 27, 1992

A “Screw-Up” Worked in MD Anderson’s Favor In Seven-Year Stint as U.S. News & World Report Top-Ranked Cancer Center

July 19, 2013

NCI Cooperative Group, Cancer Center Trials Listed

October 28, 2005